Yi Pan
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Lung Cancer Treatments and Mutations
- Prostate Cancer Treatment and Research
Papers in
-
- Epigenetics and DNA Methylation 5
- Surgery 11
- Bladder and Urothelial Cancer Treatments 4
- Co-authors
- Ulf S.R. Bergerheim (13 shared papers)Ka‐Fai To (10 shared papers)Raymond Wai Ming Lung (8 shared papers)Joanna H. Tong (5 shared papers)Anthony W.H. Chan (7 shared papers)Wing P. Chak (4 shared papers)Peter Ekman (8 shared papers)Hideyasu Matsuyama (5 shared papers)
In The Last Decade
Yi Pan
55 papers receiving 1.7k citations
Yi Pan's Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 461
- Pulmonary and Respiratory Medicine 528
- Hepatology 104
- Oncology 323
- Pathology and Forensic Medicine 189
Countries citing papers authored by Yi Pan
This map shows the geographic impact of Yi Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Pan more than expected).
Fields of papers citing papers by Yi Pan
This network shows the impact of papers produced by Yi Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Pan. The network helps show where Yi Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non–Small Cell Lung Carcinoma with Poor Prognosis Hit paper breakdown → | 2016 | 337 |
| 2 | 2018 | 118 | |
| 3 | 2015 | 108 | |
| 4 | 1995 | 104 | |
| 5 | Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. | 1994 | 64 |
| 6 | 2015 | 63 | |
| 7 | 2018 | 62 | |
| 8 | 2020 | 60 | |
| 9 | 1999 | 51 | |
| 10 | 2018 | 43 | |
| 11 | 2002 | 42 | |
| 12 | 1999 | 40 | |
| 13 | Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer. | 2001 | 38 |
| 14 | Expression of ABCG2 and its significance in colorectal cancer. | 2010 | 37 |
| 15 | 2023 | 34 | |
| 16 | 2001 | 33 | |
| 17 | 1994 | 33 | |
| 18 | 2019 | 31 | |
| 19 | 2014 | 29 | |
| 20 | 2023 | 28 |
About Yi Pan
Yi Pan is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 56 papers that have together received 1.7k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Genetic factors in colorectal cancer (5 papers), Prostate Cancer Treatment and Research (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Metal-Organic Frameworks: Synthesis and Applications (3 papers), Hippo pathway signaling and YAP/TAZ (3 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Cancer Research (461 citations), Pulmonary and Respiratory Medicine (528 citations), Hepatology (104 citations), Oncology (323 citations) and Pathology and Forensic Medicine (189 citations). Yi Pan has collaborated with scholars based in China, Sweden and Hong Kong. Frequent co-authors include Ulf S.R. Bergerheim, Ka‐Fai To, Raymond Wai Ming Lung, Joanna H. Tong, Anthony W.H. Chan, Wing P. Chak, Peter Ekman, Hideyasu Matsuyama, Lau Y. Chung and Bernhard Tribukait. Their work appears in journals such as Genes Chromosomes and Cancer, The Prostate, Cytometry, Molecular Cancer and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.